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Purpose. To study the risk factors, microbial profile, antibiotic susceptibility pattern, and outcome for microbial keratitis over the
past 10 years in a tertiary center in Hong Kong. Methods. All cases with corneal scraping performed in Queen Mary Hospital,
Hong Kong from January 2004 to December 2013 were included. Clinical outcome was defined as poor if the final visual acuity
(VA) was abnormal or worse than presenting VA, a major complication occurred, or therapeutic keratoplasty was required. Results.
347 scrapes were performed in the 10-year period growing 130 microorganisms (32.3% culture positive rate). Contact lens use
was the commonest risk factor. The commonest isolates were coagulase-negative Staphylococcus and Pseudomonas aeruginosa.
Fluoroquinolone susceptibility was tested in 47 Gram-negative bacteria with 93.6% susceptibility (100% for Pseudomonas). 90.7%
of cases had good visual outcome.Multivariate logistic regression showed age (𝑝 = 0.03), trauma (𝑝 = 0.006), and ulcer size >3mm
(𝑝 = 0.039) to be independently associated with poor outcome. Conclusion. There was no shifting trend in the isolate distribution
or emergence of resistant strains in our study. Contact lens wear was the commonest risk factor, with Pseudomonas being the most
frequent isolate in this group. It remained 100% susceptible to fluoroquinolones and 97% cases had good visual outcome.
1. Background
Microbial keratitis is one of the commonest causes of corneal
blindness worldwide. The mainstay of diagnosis is corneal
scraping. However, the clinician has to decide on the antibi-
otic regime before the culture and antibiotic susceptibility
results are available. This decision is often based on patient’s
demographics, risk factor profile, and the local microbial
distribution pattern. As geographical and climatic factors
result in regional differences in the pattern of microbial
isolates, local epidemiologic studies are necessary [1]. The
antibiotic susceptibility profile is also important in view of
reports on the emergence of methicillin or fluoroquinolone
resistance in North America and Asia in the past decade
[2–5]. The in vivo resistance correlates with a worse clinical
outcome as well [6].
In Hong Kong, the last large-scale epidemiological study
on microbial keratitis was over 15 years ago [7]. The aim
of this study was to investigate for any changes in the
microbiological and antibiotic susceptibility pattern, risk
factors profile, and clinical outcome in a Hong Kong tertiary
referral center over the past 10 years.
2. Method
This retrospective study included all patients who received
diagnostic corneal scraping in Queen Mary Hospital, Hong
Kong, from January 2004 to December 2013. Corneal scrap-
ings were performed with a sterile number 15 surgical blade
under topical anesthesia. Samples were routinely inoculated
onto chocolate, blood, and Sabouraud’s agar plates and sent
to the Department of Microbiology for culture and antibiotic
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Table 1: Risk factors for microbial keratitis.
Risk factors Number of cases1 Most common microbial isolate
(1) Contact lens use 111 Pseudomonas
(2) Ocular trauma 27 Staphylococcus aureus
(3) Presence of keratopathy or ocular surface disease 82 Coagulase-negative Staphylococcus
(i) Presence of corneal scars or irregular ocular surface 19 (23.2%)
(ii) History of corneal surgical procedures 11 (13.4%)
(iii) Exposure keratopathy 10 (12.2%)
(iv) Bullous keratopathy 7 (8.5%)
(v) Superimposed infection following an epithelial defect 7 (8.5%)
(vi) Superimposed infection following active herpetic keratitis 6 (7.3%)
(vii) Dry eyes with corneal involvement 5 (6.1%)
(viii) Neurotrophic keratopathy 3 (3.7%)
(ix) Others 13 (15.9%)
(4) Systemic conditions2 482 Coagulase-negative Staphylococcus
Immunocompromised state
(i) Diabetes mellitus 25 (52.1%)
(ii) End-organ failure 8 (16.7%)
(iii) Use of immunosuppressant including steroids 7 (14.6%)
(iv) Terminal malignancies 3 (6.3%)
Mental illness with poor self-care3 17 (35.4%)
1214 cases (82.3%) had at least 1 risk factor identified. 55 cases (21.2%) had more than 1 risk factor.
2Some cases had multiple conditions.
3This group included moderate-to-severe mental retardation, moderate-to-severe dementia, and schizophrenia with self-neglect.
susceptibility testing. Any positive growths from the speci-
mens would be reported by themicrobiologist.The antibiotic
susceptibility was determined according to the CLSI (Clinical
and Laboratory Stand Institute) criteria.
2.1. Data Collection. All culture and antibiotic susceptibility
results obtained from the corneal scrapings were retrieved
from the Department of Microbiology database. Cases notes
were reviewed. Data collection included patient demograph-
ics, risk factors profile, and the clinical progress. Cases with
incomplete clinical data were excluded from the analysis.
These included cases that defaulted follow-up after initial pre-
sentation orwith incomplete documentation of risk factors or
progress in the clinical notes. Cases with absence of corneal
infiltrates were also excluded from analysis.
Risk factors considered, including contact lens use,
trauma, history of corneal and ocular surface disorders,
and presence of systemic illness (which either resulted in
immunocompromised state or poor self-care), were shown
in Table 1. For clinical features, size and location of corneal
ulcer and presence of hypopyon in the anterior chamber
were recorded. Size of lesion was categorized as small if less
than 3mm or large if more than 3mm. Presence of good
initial response to antibiotic was defined as improvement in
pain or reduction in size of ulcer or infiltrate in the first
48–72 hours. Clinical outcome was defined as good if the
visual acuity at final visit was better than 0.7 (Snellen), or,
in cases where there was poor premorbid visual acuity from
preexisting ocular pathology, there should be no drop in final
visual acuity as compared with presenting visual acuity. Poor
outcome was defined if there was a drop in visual acuity or
if a major complication occurred, which included corneal
perforation, endophthalmitis, or had therapeutic keratoplasty
performed.
2.2. Analysis. Statistical analysis was performed with SPSS
version 21 (IBM). The number of each cultured isolate
and antibiotic resistance pattern were tested with Spearman
correlation for any changing trends over the 10-year period.
The microbial pattern in different risk factor groups was
compared with chi-square test. Univariate and multivariate
analyses by logistic regression were used to examine for
any risk factors affecting the outcome. The study received
approval by the Institutional Research Ethics Board of the
University ofHongKong (reference number: UW14-043) and
complied with the Declaration of Helsinki.
3. Results
347 corneal scrapings were performed in the 10-year period.
43.4% were males and 53.5% were females. Mean age was
46.2 ± 21.1 (range 10–96; median 46, interquartile range 27–
63). The peak incidence occurred in the 21–30 subgroup (68
cases (19.6%), mean 25.1 ± 2.9) and the 51–60 subgroup (56
cases (16.1%), mean 54.6 ± 2.7). After exclusion, 260 cases
were available for analysis of risk factors and 241 cases for
clinical outcome (19 cases defaulted follow-up before healing
of ulcer).
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Table 2: Distribution of microbial isolates.
Number of
isolates
Percentage
(%)
Gram-positive bacteria:
Coagulase-negative Staphylococcus 34 50.0
Staphylococcus aureus 17 25.0
Other Gram-positive cocci∗ 7 10.3
Other Gram-positive rods# 8 11.8
Other Gram-positive bacteria∧ 2 2.9
Total 68 100.0
Gram-negative Bacteria:
Pseudomonas 33 66
Enterobacteriaceae† 8 16
Other Gram-negative bacteria‡ 9 18
Total 50 100
Fungi:
Fusarium 4 33.3
Candida 3 25
Others∗∗ 5 41.7
Total 12 100
Note: 16 cases were polymicrobial cases.
∗Gram-positive cocci include other Streptococcus and Staphylococcus strains.
#Gram-positive rods include Bacillus, Corynebacterium, and Diphtheroid.
∧Other Gram-positive includeMicrococcus.
†Enterobacteriaceae include Escherichia coli, Klebsiella, Serratia, and Cit-
robacter.
‡Other Gram-negative bacteria include Moraxella, Flavobacteria, Acineto-
bacter,and Propionibacterium.
∗∗Others include Aspergillus, Penicillium, and Rhodotorula.
3.1. Culture Results. The distribution of microbial isolates
was shown in Figure 1 and Table 2. 32.3% (112) scraping
sample was culture positive and grew 130 microorganisms.
16 cases had polymicrobial growth. The most common bac-
terial growths were coagulase-negative Staphylococcus, Pseu-
domonas aeruginosa, and Staphylococcus aureus. Neither the
Gram-positive nor the Gram-negative group demonstrated a
shifting trend over the 10-year period (𝑝 = 0.634 and 0.722;
𝑟 = 0.172 and −0.129, resp.).
3.2. Antibiotic Resistance. Fluoroquinolone susceptibility was
tested in 47 Gram-negative bacteria with 93.6% suscep-
tibility. Among 17 cases of Staphylococcus aureus and 25
cases of coagulase-negative Staphylococcus tested for methi-
cillin resistance, there was 1 case (5.9%) of methicillin-
resistant Staphylococcus aureus (MRSA) and 7 cases (28%)
of methicillin-resistant coagulase-negative Staphylococcus
(MRCNS). All of these were susceptible to vancomycin. No
significant increasing trend in methicillin resistance was
observed (𝑝 = 0.139; 𝑟 = −0.502). 92 isolates were tested for
gentamicin with 88.0% susceptibility. It was higher (93.3%)
if we only considered Gram-negative bacteria (45 isolates).
All Pseudomonas were 100% susceptible to fluoroquinolones,
aminoglycosides, and ceftazidime.
3.3. Risk Factors. 82.3% (214 cases) had at least 1 identifiable
risk factor and 21.2% (55 cases) had multiple risk factors.
The distribution of the risk factors was shown in Table 1.
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Figure 1: Distribution of Gram-positive, Gram-negative bacteria,
and fungus over 10 years.
Contact lens wear was the most common, accounting for
42.7% (111 cases).The average age was 28.4 (range 11–69), with
male : female ratio 1 : 2. 34.2% (38 cases) had positive culture
and Pseudomonas accounted for half of the cultured bacteria.
Fusariumwas cultured in 3 cases. When compared with non-
contact lens-related cases, contact lens-related keratitis grew
a statistically significant higher proportion of Gram-negative
bacteria (𝑝 < 0.0005). The second commonest risk factor
was the presence of keratopathies or ocular surface disease,
with 82 cases (31.5%). Average age was 58. 52.3% of these
cases were culture positive and Gram-positive cocci were
the commonest isolate (14 coagulase-negative Staphylococcus
and 10 Staphylococcus aureus), followed by Pseudomonas (7
cases). When compared with cases without keratopathies or
ocular surface diseases, this group yielded significantly more
Gram-positive growths (𝑝 = 0.007). 48 cases (18.5%) had
either immunocompromised state or mental illness resulting
in poor self-care. Many of these cases had multiple comor-
bidities. Average age was 62.4 years. 39.6% of these cases grew
Gram-positive bacteria in which 16 cases were Gram-positive
cocci. Eight cases (16.7%) grew Gram-negative bacteria with
Pseudomonas predominance (7 cases, 15.6%). For traumatic
cases, there were 27 cases (10.4%), with average age 40.3.Most
were superficial injury causing corneal abrasion but with
delayed presentation. 22.2% (6 cases) had positive bacterial
culture and all were Gram-positive cocci with Staphylococcus
aureus being the commonest.
3.4. Presenting Features. 225 cases were available for analysis,
as others were excluded due to poor documentation of lesion
size owing to a transition to computerized record around
2008 in our center. 197 cases (87.6%) had initial corneal ulcer
smaller than 3mm while 28 cases (12.4%) were larger than
3mm. Presence of hypopyon was found in 30 cases (13%).
Pseudomonas was significantly associated with the presence
of hypopyon on presentation (48.3% in Pseudomonas versus
13.5% in non-Pseudomonas, 𝑝 < 0.0005, chi-square test).
3.5. Antibiotic Choice, Initial Response, and Clinical Outcome.
91.5% of cases started topical fluoroquinolones as first line
4 Journal of Ophthalmology
treatment. 38% of these cases were combined with amino-
glycosides (gentamicin). 6.5% (17 cases) started with com-
bination of fortified antibiotics (ceftazidime plus tobramycin
or vancomycin). 3.5% (9 cases) received antifungal agents on
top of initial antibacterial treatment (as these were referred as
suspected fungal cases). Topical antifungal agents employed
included topical natamycin and/or 0.1% amphotericin B.
Systemic antifungal agents with voriconazole, ketoconazole,
or fluconazole were used in 3 cases.
90% (239) of cases showed good initial response with
improvement in either pain, infiltrate size, epithelial defect
size, or amount of hypopyon. 12% (32) of cases needed to step
up treatment, either due to lack of treatment response after
48–72 hours or as guided by the antibiotic susceptibility result
of the corneal scrape.
90.7% had good outcome and 9.3% (24 cases) had poor
outcome. Two cases developed endophthalmitis resulting
in blind eye. One culture-negative case had corneal biopsy
performed at a later stage which found Acanthamoeba.
One initially culture-negative case required enucleation and
histology revealed fungal infection. Therapeutic penetrating
keratoplasty was performed in one case.
Logistic regression was performed to analyze where the
clinical outcome was affected by the factors shown in Table 3.
Older age group (average 62.7), history of trauma, and
presenting lesion size >3mm were found to be associated
with poor outcome with both univariate (𝑝 = 0.05, 0.009,
and 0.044, resp.) andmultivariate (𝑝 = 0.03, 0.006, and 0.039,
resp.) analyses.
4. Discussion
The overall positive culture rate in this series was 32.3%.
When compared with other keratitis studies published in the
past decade (Table 4), their culture growth rate of corneal
scrapings ranged from 25.6% to 78% [1, 8, 10–12, 14–17, 21, 22].
Ours was among the lower yield range. One main reason
was that our hospital was a regional tertiary center. Most
cases that presented to us have already been started on top-
ical antimicrobial therapy. Our center also received referral
from private ophthalmologists, and this group of partially
treated patients often has already received broad-spectrum
antibiotics therapy, commonly topical levofloxacin or mox-
ifloxacin. Another reason was the indication of performing
corneal scraping was not limited to infectious keratitis. In
some cases, the clinical diagnosis was noninfective, such as
peripheral ulcerative keratitis or herpetic keratitis. Clinically
there was absence of suppurative infiltrate. Nevertheless,
corneal scraping was performed in order to exclude presence
of secondary bacterial infection as this had important impli-
cation in the management plan. These cases, as expected,
yielded negative culture result and contributed to the lower
overall rate of positive growth.
We had a slightly higher proportion of Gram-positive
than Gram-negative bacteria, with coagulase-negative Staph-
ylococcus (CNS) and Pseudomonas being the most common
growths, respectively. Most other studies in developed coun-
tries also had similar findings where there were a higher
Table 3: Univariate logistic regression of risk factors, presenting
features and isolates with the clinical outcome. Age, traumatic
etiology, and ulcer size >3mm predicted a poor clinical outcome.
Variables 𝑝 value
Gender 0.447
Age 0.050
Contact lens use 0.889
Trauma 0.009
History of keratopathy or corneal surgery 0.123
Systemic immunocompromised state or mental
illness with poor self-care 0.924
Initial response to antimicrobial therapy 0.503
Presence of hypopyon 0.990
Size of ulcer∗ 0.044
Bacterial isolate∗∗ 0.245
∗Size of ulcer: classified into large (>3mm) and small (<3mm).
∗∗Divided into 5 groups for analysis: no growth; Gram-positive cocci;
Pseudomonas; other microbial agents; polymicrobial cases.
proportion of Gram-positive bacteria, except two studies
from the United Kingdom [14, 16]. But, in the studies
performed in Asian developing countries, they had more
fungal keratitis as majority were traumatic keratitis [18–20].
On the other hand, in developed Asian regions, such as
Shanghai, Beijing, Taiwan, Japan, and Hong Kong (current
study), the findings resembled those of developed European
and American regions, where the most common risk factors
were contact lens use and fungal keratitis only consisted of
a small portion of cases [3, 10, 21, 23]. This highlighted the
fact that wide geographical variation existed even within the
same continent, and the clinician should pay attention to the
background and travel history of the patient especially in
international cities like Hong Kong.
The Hong Kong Keratitis Study Group studied 223 cases
in 1997 to 1998 [7]. The positive culture rate was 35%, which
was very similar to our series. The main risk factors were
history of ocular surface disease followed by trauma, and
the most prevalent causative bacteria were Pseudomonas.
Compared to them, our series had a higher portion of contact
lens-related keratitis. The shift in the risk factor for keratitis
could be due to an increasing number of teenagers and young
patients using contact lens and with poor contact lens habit.
This suggestion could be supported by another study that
looked into 18 cases of pediatric keratitis (aged under 18)
from 2001 to 2010 in Hong Kong [24]. In their series, contact
lens use was the most common risk factor. In our study,
15% (17 patients) of the contact lens-keratitis subgroup were
aged 18 or younger. In both their study and our contact
lens-keratitis subgroup, Pseudomonas followed by coagulase-
negative Staphylococcus was the most common pathogen.
This showed consistency in the microbial pattern in con-
tact lens-related keratitis in Hong Kong. Pseudomonas also
remained fully susceptible to third-generation cephalosporin,
aminoglycosides, and quinolone antibiotics in both studies,
which spanned over 15 years.Thiswas very reassuring as these
were the most commonly used agents by ophthalmologists in
Hong Kong, and no increase in resistant strains was reported.
Journal of Ophthalmology 5
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In our study, fluoroquinolone susceptibility was tested in
47 Gram-negative bacteria with 93.6% susceptibility. When
compared with a recent 10-year study in UK, they reported a
94.4% susceptibility to ciprofloxacin for their Gram-negative
bacteria [16]. In another recent 11-year study in Toronto, they
found a 97.4% susceptibility to ciprofloxacin for their Gram-
negative isolates, with 97.8% for Pseudomonas aeruginosa
[1]. Therefore, our fluoroquinolone susceptibility rate was
actually quite similar to those reported by overseas studies.
As for Pseudomonas aeruginosa, we found 100% susceptibility
to fluoroquinolone in our series. The low resistant rate of
Gram-negative bacteria in our series, including Pseudomonas
aeruginosa, may be related to the relatively low usage of
quinolone in general in Hong Kong. There were two main
reasons for the low usage of quinolone. First of all, the
most commonly prescribed antibiotic eye drops in our
primary care setting was chloramphenicol instead of fluo-
roquinolones. Fluoroquinolone eye drops were mainly only
prescribed by ophthalmologists and therefore abuse of these
antibiotic agents was less of an issue. Secondly, in patients
with systemic infections such as pneumonia, our physicians
always try to avoid the use of quinolone as a first line
agent. This is because of the high incidence of tuberculosis
in Hong Kong, and the widespread use of fluoroquinolone
is discouraged to prevent the emergence of quinolone-
resistant tuberculosis. The zero resistance to fluoroquinolone
in our Pseudomonas cases could also explain the good initial
treatment response (90%) in our series. We would continue
fluoroquinolone monotherapy as the initial first line therapy
in most of our infectious keratitis cases. In fact, Shalchi et al.
gave same recommendation in their 10-year review in United
Kingdom [16]. A recent meta-analysis also supported the use
of fluoroquinolone as the first choice for empirical treatment
in most cases of suspected bacterial keratitis too [25].
Older age, larger ulcer size, and traumatic caseswere asso-
ciatedwith poor outcomewith a loss of final visual acuity.The
older age group patients often had coexisting keratopathies,
ocular surface diseases, or systemic diseases. Other study also
reported worse outcome in patients over 60 years old [9].
We would recommend antibiotic with broad Gram-positive
coverage in older patients since we found a significantly
higher proportion of Gram-positive isolates in both presence
of keratopathy and presence of systemic conditions. Larger
lesion size (>3mm) was also associated with poor outcome,
as this group of patients often had delayed presentation or
factitious pathogens, although we found no correlation of
microorganisms with the ulcer size. We would recommend
admission for fortified antibiotic for these patients to ensure
a better compliance to therapy and closer monitoring.
Limitations.This studywas limited by its retrospective design.
The decision of performing corneal scraping in clinically
bacterial keratitis cases was not unified. Some early cases
with small lesions (<1mm) were treated empirically without
obtaining corneal scraping. As a result, there was very
likely an underreporting of the number of bacterial keratitis
cases and cultured isolates. The study was also carried out
in a tertiary referral centre and therefore was treating a
higher portion ofmore difficult or treatment-refractory cases.
The number of underlying risk factors might have been
overlooked by the attending clinician as well. For example,
the presence of keratopathies or systemic illness might not
have been performed consistently in a retrospective study.
For the antibiotic susceptibility testing, different groups
of bacteria were tested with different sets of antibiotics.
For example, fluoroquinolones were not routinely tested
in Gram-positive isolates. Therefore, we could not directly
compare the percentage of fluoroquinolone resistance with
other studies. Regarding the clinical outcome, we could only
rely on parameters such as final visual acuity and cases
with complications. The exact number of days for complete
resolution of infiltrate and reepithelialization could not be
determined as the follow-up intervals varied among different
clinicians and in different cases.
5. Conclusions
This study was the largest case series of consecutive corneal
scrapings in Hong Kong. It identified contact lens wear as
the most common risk factor with Pseudomonas being the
most prevalent pathogen in this group. Its susceptibility to
most first line antibiotic agents remained 100% throughout
the decade, and monotherapy with fluoroquinolones was
an effective first line treatment in most of our cases. More
aggressive treatment approach should be employed in kerati-
tis belonging to the older age group, larger presenting ulcer
size, and traumatic cases in view of their association with a
poorer outcome.
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